Immatics Events Q4 2018

| News

Immatics, a leading company in the field of cancer immunotherapy, will be attending the industry conferences and meetings listed below. You can also download the complete list here: Immatics Events Q4 2018. 

To arrange meetings with Immatics at any of the events, please contact info@immatics.com

 

FDA/CDER-HESI Workshop on Preclinical and Translational Safety Assessment of CD3 Bispecifics

October 1st-2nd, Silver Spring, Maryland, USA

 

ESMO Congress 2018

October 19th-23rd, Munich, Germany

 

Strategic and Operational Challenges of Oncology&IO Drug Development

October 25th-26th, Philadelphia, USA

 

European Antibody Congress 

October 29th-31st, Basel, Switzerland

 

World Immunotherapy Congress 2018

October 29th-31st, Basel, Switzerland

 

5th USP Workshop on Therapeutic Peptides

November 5th-6th, Rockville, Maryland, USA

 

Bio Europe 2018

November 5th-7th, Copenhagen, Denmark

 

SITC 2018

November 7th-11th, Washington, USA

 

Texas Life Science Forum

November 8th, Houston, USA

 

Protein & Antibody Engineering Summit, PEGS Europe

November 12th-16th, Lisbon, Portugal

 

60th ASH Annual Meeting & Exposition

December 1st-4th, San Diego, USA

 

Cell Therapy Manufacturing & Gene Therapy Congress

December 4th-5th, Amsterdam, Netherlands

 

Antibody Engineering & Therapeutics

December 9th-13th, San Diego, USA

 

Press Contact

Dr Nikola Wiegeler

Press contact,
Immatics Biotechnologies GmbH

+49 7071 5397-0

Go back